Apellis Pharmaceuticals News

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene

Apr 19 19:30 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dunlop A. Sinclair

Apr 15 16:15 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Deschatelets Pascal

Apr 9 16:30 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene

Apr 2 16:14 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dunlop A. Sinclair

Mar 20 17:23 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DeLong Mark Jeffrey

Mar 19 16:09 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chopas James George

Mar 18 16:21 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nicholson Nur

Mar 14 16:25 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Deschatelets Pascal

Mar 11 16:16 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Watson David O.

Mar 8 07:50 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Francois Cedric

Mar 5 16:13 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene

Mar 5 16:13 ET

Apellis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(9.4%),Oleg Nodelman(9.4%), etc.

Feb 14 17:23 ET

Apellis Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(5.3%)

Feb 14 14:31 ET

Apellis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(9.9%),Behzad Aghazadeh(9.9%)

Feb 14 09:27 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Adam J.

Feb 13 18:06 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Watson David O.

Feb 13 17:47 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene

Feb 13 17:11 ET

Apellis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.06%)

Feb 13 17:01 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Francois Cedric

Feb 13 16:53 ET